Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Microbot Medical Inc.
< Previous
1
2
3
Next >
Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office
November 08, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study
October 31, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024
October 24, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company
October 19, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY® Robotic Surgical System
October 17, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial
September 27, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023
September 08, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System
August 15, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board
August 10, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe
July 25, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board
July 11, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
June 29, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings
June 28, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 27, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Expand IP protection in Japan
June 22, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe
June 16, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 06, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
June 02, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System
June 02, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process
May 31, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial
May 25, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
May 24, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
May 23, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
May 23, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
May 22, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
May 22, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases
May 18, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
May 08, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical Announces Final Data From Its Recent Animal Study
May 05, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization
May 03, 2023
From
Microbot Medical Inc.
Via
GlobeNewswire
Tickers
MBOT
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.